search
Company Information
USD
56.26
- (6.3%)
NASDAQ:ACLX, ARCELLX INC
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.

Address

800 Bridge Parkway
Suite A

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. David Charles Lubner
Director
Ms. Jill Carroll, M.S.
Director
Mr. Rami Elghandour
CEO/Chairman of the Board/Director/President
Dr. Ali Behbahani, M.B.A.,M.D.
Director
Ms. Olivia C. Ware, M.B.A.
Director
Dr. Kavita K. Patel, M.D.
Director
Mr. Derek Yoon
Director
Ms. Michelle Gilson
CFO/Chief Accounting Officer
Dr. Christopher Heery, M.D.
Chief Medical Officer
Dr. David Tice, PhD
Chief Scientific Officer

Ownership

Institution Holdings

Perceptive Advisors LLC
4,544,809 (8.608%)
FMR Inc
4,379,169 (8.294%)
New Enterprise Associates 15 LP
3,745,262 (7.212%)
NEA Management Company, LLC
3,745,262 (7.094%)
Paradigm Biocapital Advisors LP
3,658,624 (6.930%)
SR ONE CAPITAL MANAGEMENT, LP
3,146,630 (5.960%)
BlackRock Inc
3,018,538 (5.717%)
Fidelity Management & Research Company LLC
2,530,480 (4.793%)
Suvretta Capital Management, LLC
2,435,974 (4.614%)
Fidelity SelectCo, LLC
2,302,371 (4.361%)

Individual Holdings

Mr. Rami Elghandour
92,339 (0.178%)
Mr. David Charles Lubner
21,659 (0.062%)
Dr. Christopher Heery, M.D.
30,303 (0.058%)
Ms. Michelle Gilson
16,310 (0.031%)
Dr. Ali Behbahani, M.B.A.,M.D.
339 (0.001%)

Funds Holdings

Vanguard Total Stock Market Index Fund
1,178,341 (2.232%)
SPDR® S&P Biotech ETF
1,051,351 (1.991%)
iShares Russell 2000 ETF
938,243 (1.777%)
Lord Abbett Developing Growth Fund
694,255 (1.315%)
Janus Henderson Global Life Science
474,254 (0.898%)
Janus Henderson Global Life Sciences Fd
474,254 (0.898%)
US Small-Cap Growth II Equity Comp
472,122 (0.894%)
T. Rowe Price New Horizons Fund
472,122 (0.894%)
Vanguard Institutional Extnd Mkt Idx Tr
467,728 (0.886%)
Fidelity Small Cap Growth Fund
393,884 (0.746%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices